Goldman Sachs
CHE icon

Goldman Sachs’s Chemed CHE Stock Holding History

Goldman Sachs’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-16,200
Closed -$1.52M – 7123
2014
Q2 		$1.52M Buy
+16,200
New +$1.44M ﹤0.01% 4284

Other funds holding CHE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Goldman Sachs's CHE Position: Q1 2026 in Review

Goldman Sachs reduced its Chemed (CHE) stake by 13% in Q1 2026, selling an estimated $8.61M and leaving 137,999 shares worth $52.1M. The position accounts for 0.01% of the portfolio, ranked #1548.

Goldman Sachs first reported a position in CHE in Q2 2013 and has held it in 52 quarters since. The position peaked at $86.7M in Q2 2018. 489 funds tracked by Wall St. Rank hold CHE as of Q1 2026.

  • Goldman Sachs held 137,999 shares of Chemed worth $52.1M as of Q1 2026.
  • Goldman Sachs sold 20,094 Chemed shares in Q1 2026, an estimated $8.61M.
  • Chemed made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1548 holding.
  • Goldman Sachs first reported a position in Chemed in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Chemed position peaked at $86.7M in Q2 2018.
  • 489 funds tracked by Wall St. Rank held Chemed as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.